Type IV Hypersensitivity

Bookmark (0)
Please login to bookmark Close
  • Briefly describe Type IV Hypersensitivity
    • Type IV hypersensitivity is T-cell mediated hypersensitivity.
    • Activated T-cells release cytokines that activate macrophages or kill cells directly.
    • Type IV hypersensitivity is useful against intracellular organisms (viruses, fungi, parasites, some bacteria).
    • Here it results in inflammation, cell destruction, and granuloma formation
  • What are the Types of Type IV Hypersensitivity reactions
    • Delayed-type Hypesensitivity (DTH)
      • CD4+ T cells secrete cytokines, activating macrophages, can lead to granulomatous inflammation
    • Direct cell cytotoxicity
      • CD8+ T cells kill target cells
  • Describe the pathogenesis of delayed-type Type IV Hypersensitivity reactions
    • Initial exposure (Sensitization)
      • Mechanism of exposure:
        • Contact sensitization with chemicals and environmental antigens
        • Intradermal or subcutaneous injection of protein antigens
        • Microbial infection
      • APCs (DCs and Macrophage) uptake antigen, are activated and secrete IL-12, IL-1, IL-6, and IL-23
      • The phagocytosed mocs are presented to naive CD4+ T-cells via MHC II
      • Naive CD4+ T-cells are activated:
        • Secrete IL-2: Autocrine growth factor that stimulates proliferation of the antigen responsive t-CELLS
      • APCs secrete IL-12 which converts CD4+ T-cells to Th1 subset
      • APCs secrete IL-1, IL-6 and IL-23 which convert CD4+ T-cells to Th17 subset
      • Effector Th1 and Th17 cells enter circulation and join the pool of memory T-cells which persist for long periods, sometimes even years
    • Re-exposure (Effector T-cell function)
      • On repeat exposure Th1 secrete IFN-y
      • IFN-y activates macrophages via the classical pathway in order to eliminate the offending antigen
        • Ability to phagocytose and kill micro-organisms is enhanced
        • Express more class II MHC molecules on the surface enhancing antigen presentation
        • Secrete TNF, IL-1 and chemokines which promote inflammation
        • Produce more IL-12, amplifying the Th1 response
      • Activate Th17 cells secrete IL-12, IL-22, chemokines and other cytokines
        • Function to recruit neutrophils and monocytes to the reaction promoting inflammation
      • Recruited macrophages and neutrophils cause tissue destruction via lysosomal enzymes and reactive oxygen species
      • Prolonged inflammation causes granulomatous inflammation whereby macrophages are activated to become epitheloid or they fuse to form giant cells
      • Granuloma formation
        • Microbe or foreign body persists within macrophages that the cell is unable to destroy
        • Sustained Th1 activation and IFN-y production causes macrophages to undergo morphologic transformation into epitheloid cells with large abundant cytoplasm
        • Some Macrophages fuse to form giant multinucleated cells
        • Examples
          • Infections: Leprosy, Tuberculosis, Schistosomiasis
          • Non-infectious conditions: Sarcodiosis, Crohn disase
          • Foreign body reaction: Berylliosis, Talcosis, Silicosis
    • Direct cell cytotoxicity – CD8+ mediated Hypersensitivity
      • CTLs recognize antigens on surface cells.
  • Give examples of Delayed Type Hypersensitivity reactions (DTH)
    • CD4+ Mediated
      • Mantoux test
      • Brucellosis
      • Lepromin test
      • Frei’s test in Lymphogranuloma Venerium
      • Tuberculin (PPD) reaction
      • Contact Dermatitis (Urushiol poison ivy)
      • Autoimmune diseases (Rheumatoid Arthritis, Psoriasis, Multiple sclerosis, IBD – Crohn)
      • Granuloma formation (Leprosy, Tuberculosis, Schistosomiasis, Sarcodiosis, Crohn disease, Berylliosis, Talcosis, Silicosis
    • CD8+ mediated
      • Type I Diabetes Mellitus
      • Graft Rejection
  • Briefly describe contact dermatitis
    • Contact dermatitis is a DTH reaction when skin comes into contact with chemical substances or drugs (poison, hair dyes, cosmetics, soaps, neomycin).
    • These substances enter the skin as small molecules (haptens) attached to proteins to form immunogenic substances.
    • Urushioll: antigenic component of poision ivy or poison oak
    • Mechanism
      • Occurs from topical exposure to chemicals and environmental antigens
      • Haptens penetrate the skin and combine with tissue proteins to form neo-antigens
      • Langerhan cells are the principle APCs in recognition of hapten-tissue protein complexes and presentation to T-cells
    • DTH leads to : eczema, rash, vesicular eruption
  • Briefly describe the Tuberculin skin test (PPD)
    • PPD is injected intradermally in sensitized persons.
    • A local area of induration appears at the injection site 48-72 hours later due to the accumulation of macrophages and lymphocytes.
    • Similar reactions in:
      • Brucellosis
      • Lepromin test in Leprosy
      • Frei’s test in Lymphogranuloma venereum
    • Morphology: Accumulation of mononuclear cells (Mainly CD4+ T-cells and Macrophages around venules producing perivascular cuffing
  • What is the mechanism behind the Tuberculin Skin Test (PPD)
    • Occurs in individuals who have been exposed to M tuberculosis (Infection, Vaccination?)
    • Delayed Type Hypersensitivity evolves over 24-48 hours
    • 4 hours after injection in sensitized individuals neutrophils accumulate around the post-capillary venules at the injection site
    • 12 hours after the injection T cells and blood monocytes infiltrate the area
    • Endothelial cells lining these venules become enlarged and the vessels leak plasma macromolecules
    • Fibrinogen escapes from the blood vessels into the surrounding tissue where it is converted into fibrin
    • Deposition of fibrin, edema and accumulation of mononuclear cells within the extravascular tissue space around the injection produces an area of induration (swollen and firm)
  • Describe the procedure and interpretation of the Mantoux test (Tuberculin Skin Test, PPD)
    • Inject 0.15mL of 5 TU PD solution intradermally on the volar surface of the lower arm using a 27G needle and tuberculin syringe
    • Produce a wheal 6-10mm diameter
    • Note the arm in which the test was administered
    • Read the skin the skin test 48-72 hours after administration
    • Note the are of induration (not erythema) in millimeters in the axis perpendicular to the long axis of the arm
    • Interpretation
      • 5mm – Immunosuppressed
      • 10mm – Individuals with risk factor to TB Endemic individuals, Injection drug users MTB lab personnel, Children younger than 4, infants, children and adolescents exposed to high-risk individuals
      • 15mm – Individuals with no known risk factors for TB
  • Describe the procedure and interpretations of the Lepromin test
    • Procedure is same as the one for the Mantoux test
    • Read 48 hours = Fernandez reaction
    • Read 3-4 weeks = Mitsuda reaction
Jeffrey Kalei
Jeffrey Kalei
Articles: 335

Leave a Reply

Your email address will not be published. Required fields are marked *